BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for Allergic Asthma. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic asthma.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.DISCUSSION: The findings from this review will be used t...
YesBackground:To inform the development of the European Academy of Allergy and Clinical Immunology’s...
Background The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of d...
BACKGROUND: There is clinical uncertainty about the effectiveness and safety of allergen immunothera...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
International audienceBackground. The European Academy of Allergy and Clinical Immunology (EAACI) is...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
BACKGROUND: To inform the development of the European Academy of Allergy and Clinical Immunonology's...
YesBackground:To inform the development of the European Academy of Allergy and Clinical Immunology’s...
Background The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of d...
BACKGROUND: There is clinical uncertainty about the effectiveness and safety of allergen immunothera...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
International audienceBackground. The European Academy of Allergy and Clinical Immunology (EAACI) is...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of dev...
BACKGROUND: To inform the development of the European Academy of Allergy and Clinical Immunonology's...
YesBackground:To inform the development of the European Academy of Allergy and Clinical Immunology’s...
Background The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of d...
BACKGROUND: There is clinical uncertainty about the effectiveness and safety of allergen immunothera...